Equity Development Investment Tbk. vs Merck Tbk. — how do they compare? Equity Development Investment Tbk. trades at Rp84 (market cap 1.31T, 2.37M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 27.2K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Equity Development Investment Tbk. is more actively traded (2.37M versus 27.2K). Which is the better fit depends on your goals.
| GSMF | MERK | |
|---|---|---|
Market Cap | 1.31T | 1.7T |
Volume | 2.37M | 27.2K |
Lot | 23.75K | 272 |
Turnover | 198.8M | 104.39M |
Average Price | 83.71 | 3,837.87 |
Value | 198.8M | 104.39M |
Indicative Equilibrium Price | 85 | 3,850 |
Indicative Equilibrium Volume | 6.5K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Equity Development Investment Tbk (the “Company”) was established in Jakarta under the name of PT Gajah Surya Arta Leasing on November 1, 1982 based on the Notarial Deed of Didi Sudjadi, S.H., No. 1, as amended by deed No. 30 dated March 6, 1985 of the same notary. The Company changed its name to be PT BDNI Capital Corporation Tbk. On February 7, 2001, it changed the named again to be PT GT Investama Kapital, Tbk.
Read more on GSMF →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →